Portfolio Update – 15th Feb 2020
Updated: Jul 3, 2020
Overall this week has been a good week with my key holdings increasing in value. I have got a new stock in my portfolio and increased my position in some others. I was expecting this week to be slow with the news of the C-19. However, the market always seems to surprise me.
I have added 1 new stock to my already rather large portfolio. This stock is Exact Sciences Corporation (EXAS) which is another addition to my Pharmaceuticals. This company is a diagnostics company that builds screening tests for colorectal cancer. EXAS has shed 20% of its value since September 2019. However, its recent reporting of its Q4 2019 earnings shows some promising signs. Its screening revenues and volumes have increased by 60% over the last year. Its latest earnings per share (EPS) is now at 54 cents per share compared to a -44 cents in the last year to year basis. Generally, it has improved in all its key metrics as compared to its 2018 numbers. I am not too sure why it fell over the last few months from its high of $120+, but I think given its recent results, getting EXAS at $93 is a steal. I have noticed that Pharmaceutical stocks are very sensitive to any announcements such as patents, tests, competition etc. Hence, I will be tracking this one closely as I do not intend to hold on to this one long term.
As mentioned in my previous post on Microsoft, I have essentially doubled my position on Microsoft. I see MSFT as a dark horse among the FAANG stocks and I regret not getting it much earlier when the price was much lower. Nonetheless, based on Microsoft’s recent performance I still think it has room to grow which is why I have increased my position.
This week I also saw my portfolio value surge up. This was primarily driven by my ETFs in Stashaway, Abbvie as well as Tesla which has shown no signs of fatigue since last week’s crazy run to the top. Personally, I would not be overly excited seeing my portfolio value jump so sharply as I fully expect it to normalise soon. The only positive I am thinking about with my gains is that it is growing my portfolio enough such that when a recession comes (I have been led to believe its just around the corner), I have some buffer and hopefully I wont go into a negative value in a short span of time.
I also expected the C-19 to have a negative impact on the market, but that effect seems to be delayed for now. Perhaps the issue is still not that great of a deal for Americans who are still not that impacted by the situation. However, as time passes I believe the US stock market will definitely be impacted.
There is no change on the dividend’s end. I was supposed to be credited with dividends from Abbvie on Friday, however my broker usually takes some time to deposit the dividends so that will be hopefully accounted for in next week’s update.
Disclaimer: This post should not be interpreted as investment advice as I am not a professional financial consultant. The objective of this blog is to share my experiences with others and receive feedback. I will provide links to my information sources to the best of my abilities, but the reader is responsible for their own due diligence